| BACKGROUND
Irritable bowel syndrome (IBS) describes a group of symptoms, including abdominal pain or discomfort, and changes in bowel movement patterns and defecation, for which a correlation between pathophysiology and symptoms is mostly lacking. 1 IBS is the most common functional gastrointestinal (GI) disorder. 2 Its diagnosis is based on criteria devised by the Rome Foundation. 3 Although almost 60% of IBS patients claim that certain foods trigger their symptoms, eliminating those foods from their diet often leads to only minor symptom improvements. 4 A recent treatment option for IBS is the use of a low Fermentable, Oligo-, Di-, Monosaccharides and Polyol (FODMAP) diet, which focuses on restricting fermentable, shortchain carbohydrates, including galacto-and fructo-oligosaccharides (GOS, FOS), disaccharides (lactose), monosaccharides (fructose) and polyols (such as sorbitol and mannitol). This diet produces gastrointestinal symptom relief by reducing the fermentable load on the colon, in order to reduce gas production and luminal distension. 5 Past theorists have hypothesised that irritable bowel syndrome is partly caused by visceral hypersensitivity and psychosocial factors,
with links between such factors as disturbed stress regulation and autonomic nervous system dysfunction and the condition's pathophysiology. 6, 7 Psychiatric comorbidities are also common in patients with IBS. 8 Yoga, based on an ancient Indian philosophy, has been adapted for use in complementary medicine, especially with regard to preventing and treating of disease. 9 Traditionally, yoga consists of body postures (sanskrit: Asana), breathing exercises (Pranayama) and meditation (Dhyana); a practice to "still the mind." 10, 11 It is hypothesised that yoga practice corrects stress-induced underactivity of the parasympathetic nervous system. 12 Yoga has been shown to reduce stress and psychological distress, in varied patient populations. [13] [14] [15] [16] [17] [18] It may prove equally effective in improving the symptoms of IBS. 19 The primary purpose of this study was to analyse the effectiveness of a yoga-based intervention compared to the use of a low-FOD-MAP diet in treating the gastrointestinal symptoms of patients with IBS. The secondary goal was to determine these interventions' potential effects on patients' perceived quality of life, perceived stress and health status, body awareness and responsiveness; whilst considering the safety of these treatments.
2 | ME TH ODS 
| Randomisation
Patients were randomly assigned 1:1 to yoga or nutrition counselling by block-randomisation with randomly varying block lengths, stratified by a history or nonhistory of diagnosed depression. The randomisation list was created by a biometrician, not involved in the study's patient recruitment or assessment, using the Random allocation software. 21 The list was password-secured and accessible only by the biometrician concerned. The latter prepared sealed, sequentially numbered, opaque envelopes containing the treatment assignments, based on this list. After the study's baseline assessments had been conducted, and written consent information had been obtained, the physician opened the lowest-numbered envelope to reveal each patient's assignment.
| Interventions

| Yoga
The yoga intervention included traditional hatha yoga group sessions of 75 minutes duration twice weekly for a period of 12 weeks. The yoga intervention was designed by a certified hatha yoga instructor, prior to the intervention, and was specifically customised for patients with IBS. Those yoga postures and breathing techniques thought to relax the body and mind, as well as asana (poses) traditionally thought to influence the digestive organs positively, were included (see supporting information). 11 The study's yoga intervention was provided by the same yoga instructor throughout. She guided patients to focus on their bodies, during their yoga classes, taking a nonjudgmental attitude towards their bodily sensations. One of the weekly classes consisted of yoga postures and yogic breathing techniques. 11 The second explored yoga philosophy 22 and yogic meditation techniques, including mantra meditation and yoga nidra (deep relaxation techniques). 23 The postures used in each class built upon the previous ones, with the difficulty and intensity levels being increased carefully as the program progressed (Table S1 ). Patients were provided with a written manual and three half-hour videos and were encouraged to practice their yoga at home every day. Prior to patients' home practice, yoga practice was introduced in class. The patients indicated their daily home practice time (in minutes) in a daily log.
| Low-FODMAP diet
Patients who were randomised to the nutrition group received 4 ses- and xylitol (such as apricots, peaches and artificially sweetened products) must be avoided. 25 To aid patients in their food choices, they were also given a set of low-FODMAP recipes, a list of foods to avoid and another of foods that they might eat instead. After the study's 12-week intervention period (elimination phase), patients rechallenged each week a different FODMAP group for 2 to 3 days during that week to test individual tolerance levels to each of the FODMAP groups (reintroduction phase). This scheme was explained to the patients in an individual counselling session. All patients completed a 6-day food diary on two occasions; once during the study screening period and a second time during the last week of the 12-week study intervention period. These diaries were scored by a nutritionist according to the amount of FODMAP consumption.
Patients' compliance with the nutritional advice given was rated by the same nutritionist. It was also self-rated by each patient. In both cases, a nonvalidated 100 mm visual analogue scale (VAS), with '0'
indicating no compliance at all and '100' indicating complete compliance, was used.
| Outcome assessment
The study's outcomes were assessed at weeks 12 and 24, after randomisation by an outcome assessor 'blinded' to patients' group allocation.
| Primary outcome
The irritable bowel syndrome severity scoring system (IBS-SSS) is a self-reported questionnaire exploring the severity and frequency of patients' pain, the degree of abdominal distension/bloating experienced, the level of patients' satisfaction with their bowel habits and the extent to which the latter interfere with patients' everyday lives. 26 Each question is scored from 0-100 on a visual analogue scale. This study used patients' gastrointestinal symptoms, as assessed by the IBS-SSS at week 12, as its primary outcome measure. All other outcomes were defined as secondary outcomes and were analysed exploratively only. This way, no a-level adjustment was necessary to maintain the overall Type I error rate of 5%. 27 The maximum achievable IBS-SSS score is 500; with higher scores indicating higher symptom severity. 29 to capture their more general health-related quality of life.
Symptoms of anxiety or depression were monitored by the hospital anxiety and depression scale (HADS). 30 Perceived Stress was assessed by using the cohen perceived stress scale (CPSS) 31 and the perceived stress questionnaire (PSQ). 32 While the CPSS is the tool most often used to assess stress in general, the PSQ is most frequently used in patients with gastrointestinal and/or psychosomatic disorders. Additional data about study participants' body awareness and responses were gathered using the body awareness questionnaire (BAQ) 33 and body responsiveness scale (BRS) 34 respectively.
Finally, patients kept diaries, which contained questions asking about the extent to which they experienced adequate relief (AR) of their IBS symptoms and/or a general global improvement. Patients' gut microbiomes were also assessed, but these results will be reported elsewhere.
| Safety
Patients were asked to record any adverse events that they had experienced during the study period, regardless of their potential relationship to the study intervention. on an IBS-SSS total score < 75, was compared between groups at weeks 12 and 24 using chi-square tests.
Explorative statistical subgroup analyses were performed to control for potential differences in the effectiveness of the interventions for patients with single IBS subtypes.
All analyses were performed using the statistical package for social sciences software (IBM SPSS Statistics for Windows, release 22.0. Armonk, NY, USA: IBM Group).
3 | RESULTS
| Patients
A total of 208 patients completed the telephone screening, of which 144 were excluded due to a lack of interest, scheduling problems or the failure to meet the study inclusion criteria (Figure 1 ). Sixty-four patients completed the assessment by the study physician; at which point five were excluded, leaving 59 patients who were enrolled in the study and randomised to either the yoga group (n = 30) or the FODMAP group (n = 29). A total of 7 patients; 3 in the yoga group (2 due to scheduling problems and 1 to a loss of interest) and 4 in the FODMAP group (2 due to difficulties with the diet, 1 due to scheduling problems and 1 due to the relapse of a major depressive episode) withdrew from the study. All patients were analysed on an intention-to-treat basis. No group differences in sociodemographic or clinical characteristics were found ( This resulted in statistically significant changes within both the yoga and the FODMAP group at week 12 (yoga: P < .001; FODMAP: P < .001) and week 24 (yoga: P < .001; FODMAP: P < .001) ( 
| Secondary outcomes
The study's secondary outcomes are summarised in the supportive information in Table S3 . No statistically significant between-group differences were found on the SF-36, except for the physical component summary subscale, which showed a statistically significant improvement in the yoga group. The CPSS and PSQ did not reveal between-group differences, but within-group comparison showed statistically significant improvements for both groups, using the CPSS, but only for the yoga group using the PSQ. The IBS-QOL showed a statistically significant between-group difference only on one subscale; namely a decrease in quality of life at week 12, related to FODMAP group patients' avoidance of some foods (P = .005).
The HADS questionnaire revealed significantly lower scores in Scores for the BAQ showed no statistically significant betweengroup differences at week 12 (P = .064), but a significant difference was found at week 24 in favour of the yoga group (P = .017). The subscale relating to the importance of interoceptive awareness (BRS-1) showed no statistically significant between-group differences at either time points and the subscale measuring perceived mind-bodyconnection (BRS-2) showed significant between-group differences at week 12 in favour of the yoga group (P = .027).
According to the patients' food diaries, at week 12, 82.4% of patients in the yoga group experienced adequate relief of their IBS symptoms vs 78.6% in the FODMAP group, although no statistically significant between-group differences were found (P = 1.000). These findings must be interpreted with care, as not all patients completed their food diaries adequately; with only 17 patients in the yoga and 14 patients in the FODMAP group answering the 'Adequate Relief' question. Global improvements at week 12 are shown in Figures S6 and S7.
| Clinical relevance
Sixteen patients in the yoga group reached a clinically relevant decrease of at least 50 points in their IBS-SSS total scores at week 12, compared to 21 in the FODMAP group (P = .180). One patient in the yoga group was in clinical remission at week 12, based on a score lower than 75 points, compared with 6 patients in the FOD-MAP group (P = .052). At week 24, a total of 3 patients in each group were in clinical remission (P = 1.000). shown. Nevertheless explorative within-group comparisons revealed statistically significant improvements in participants' overall gastrointestinal symptoms for both groups. Significant between-group differences were found in favour of the yoga group with regard to patients' levels of anxiety, body awareness and body responsiveness.
| Safety
The FODMAP diet had a nonsignificant tendency (P = .052) to induce remission more frequently than yoga, at 12 weeks, but this tendency was not seen at 24 weeks (P = 1.000). Only 1 randomised, controlled trial has studied the outcomes of a low-FODMAP diet for more than 6 weeks to date and more data on the long-term outcomes of a low-FODMAP diet are needed. 38, 39 With regard to patient safety, yoga has occasionally been associated with serious adverse events in some case studies, 40 but most systematic reviews of yoga interventions, in varied patient populations, have failed to find such links. 13, 14, 16, 19, 41 No serious adverse events related to either yoga, or to patients' adoption of a low-FODMAP diet, were observed during the current study.
The value of a low-FODMAP diet is seen by some commentators as controversial. While the related carbohydrates are poorly absorbed in the small intestine, leading to increased intestinal osmolality and gas production due to their rapid fermentation and osmotic action, fructans and galacto-oligosaccharides serve as prebiotics. 42, 43 It has been shown that low-FODMAP diets are effective in reducing bowel symptoms, 44 while they alter the colonic luminal microenvironment, possibly due to a lowered content of these prebiotics. 5, 45 Unfortunately, no published data on the influence of hatha yoga on the gut microbiome exist to date. Since the latter is hypothesised to be involved in the aetiology of IBS and depression, the impact of a low-FODMAP diet and yoga on the gut microbiota warrants further research in this context. 46, 47 Both of the current trial interventions require adequate supervision and are, thus, relatively cost-intensive.
Adopting a low-FODMAP diet requires patients to engage in intensive meal planning; supervised closely by well-trained personnel.
Such factors would offer considerable challenges if such diets were implemented in clinical practice. Moreover, the restrictions demanded by a low-FODMAP diet might lead to nutritional inadequacy and foster disordered eating. 43 In contrast, yoga could potentially enhance body awareness and responsiveness; lessening the occurrence of disordered eating attitudes. 34 A low-FODMAP-diet was found to improve patients' overall IBS symptoms in 4 of 4 studies reported elsewhere. 48 Most studies excluded IBS-C patients and as a result the low-FODMAP diet has been most extensively studied in IBS-D patients. The current trial found no statistically significant differences in an explorative subgroup analysis, comparing the effectiveness of a low-FODMAP diet in IBS-C and IBS-D patients. Elsewhere, Chumpitazi and colleagues have linked gut microbiome biomarkers to patients' clinical responses to a low-FODMAP diet, leading them to speculate that such diets may work differently for different patients. 49 With regard to the yoga intervention, it is important to note that the yoga classes delivered in the current trial were purpose-designed and adapted to patients' needs. The trial's yoga intervention encompassed philosophical elements, not usually included in conventional asana-based yoga classes; enhancing the psychological dimensions of the approach. Gut-directed hypnotherapy is another psychological therapy that has claimed to improve patients' IBS symptoms. 50 When such hypnotherapy was compared to the adoption of a low-FODMAP diet, in a randomised controlled study, neither intervention was found to be superior. 51 It should also be borne in mind that the current trial's yoga intervention was developed and delivered by an experienced yoga instructor, well-trained in the field, and was supported with videos to encourage patients to practice at home. These sessions were delivered twice a week; more often than the yoga interventions delivered in other studies. The latter were often less intensive, with either weekly yoga sessions or teaching delivered solely via videos for home-based practice. 
| Strengths and weaknesses
The strengths of this trial include its randomised controlled design, its ability to control for nonspecific therapy effects via the use of an active control group and its 'blinding' of outcome assessors. Its primary limitations are its monocentric design, its inability to 'blind' patients with regard to the allocated interventions and the subjective self-report nature of the outcome measures used to explore patients' gastrointestinal symptoms. The IBS-SSS may also fail to detect changes in patients with mild IBS, scoring lower than 175 points. 
